Sign in
Download Opera News App

News Politics




European politics

EU drug regulator reviewing woman's death in Belgium after getting J and J shot

The European Union's medication controller said on Wednesday it is inspecting the demise of a lady in Belgium who endured a blood coagulation, and low platelets in the wake of accepting Johnson and Johnson's COVID-19 immunization, the principal report of a casualty following the antibody. 

The European Medicines Agency (EMA) said it has asked the US drugmaker to do a progression of extra investigations to help evaluate a potential connection between the shot, and an uncommon thickening condition known as apoplexy with thrombocytopenia disorder (TTS). 

It said it is evaluating the situation in Belgium with different reports of blood clusters with the Belgian and Slovenian prescriptions offices. 

Prior on Wednesday, Belgium suspended utilization of J&J's Janssen COVID-19 immunization on individuals younger than 41, after the passing of a lady who was conceded to clinic with extreme apoplexy and platelet lack. 

She was accounted for to be Slovenian, despite the fact that Reuters couldn't affirm this. 

As of May 20, more than 1.34 million portions of J&J's Janssen shot had been controlled in the EU, EMA said. 

EMA and public specialists will keep on checking the immunization's security and viability and give further updates as fundamental, it said.

Source: SABC News

Content created and supplied by: Lmabunda (via Opera News )

Belgium EMA European Medicines Agency European Union Johnson


Load app to read more comments